The drug significantly cut the risk of developing severe disease and patients were twice as likely to recover versus placeboOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.